Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Change in Receivables (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Change in Receivables for 16 consecutive years, with $10.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 154.1% to $10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.0 million, a 3121.3% increase, with the full-year FY2025 number at $75.0 million, up 3121.3% from a year prior.
  • Change in Receivables was $10.1 million for Q4 2025 at Acadia Healthcare Company, down from $22.3 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $31.0 million in Q1 2025 to a low of -$18.6 million in Q4 2024.
  • A 5-year average of $7.8 million and a median of $8.3 million in 2022 define the central range for Change in Receivables.
  • Biggest YoY gain for Change in Receivables was 657.62% in 2024; the steepest drop was 1431.44% in 2024.
  • Acadia Healthcare Company's Change in Receivables stood at -$11.1 million in 2021, then soared by 158.24% to $6.4 million in 2022, then plummeted by 118.87% to -$1.2 million in 2023, then plummeted by 1431.44% to -$18.6 million in 2024, then surged by 154.1% to $10.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Change in Receivables are $10.1 million (Q4 2025), $22.3 million (Q3 2025), and $11.7 million (Q2 2025).